Cardiovascular disease

Strep A bacteria, common in children, can lead to serious complications like rheumatic heart disease (RHD) when infections are untreated, especially in communities with limited healthcare access. Professor Mark Walker’s team has made major strides to develop a vaccine.

In 2024, the Critical Care Research Group celebrated 20 years of improving outcomes through patient-centric research.

The first-ever drug to treat heart attack and protect donor hearts will now move to human clinical trials

The Critical Care Research Group has joined IMB to help accelerate translational research

A molecule sourced from funnel web spider venom shows promise as a safe and effective drug for heart attacks.

Professor Glenn King has been awarded the prestigious prize for his work in developing a sustainable way to increase food production.

IMB researchers have transformed fear into something more positive with their venom research.

A research collaboration with Moderna to develop a Strep A vaccine has secured $8 million in philanthropic funding.

Associate Professor Frederic Gachon explains how shift work affects our health.